|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Costs of revenue | |||||
| Gross profit | |||||
| General and administrative expenses | |||||
| Sales and marketing expenses | |||||
| Research and development expenses | |||||
| (Gain) loss on sale of businesses | |||||
| Gain (Loss) on Disposition of Property Plant Equipment | |||||
| Asbestos-related benefit, net | |||||
| Restructuring costs | |||||
| Operating income | |||||
| Interest expense (income), net | |||||
| Interest expense | |||||
| Interest income | |||||
| Other non-operating income, net | |||||
| Income from continuing operations before income tax | |||||
| Income tax expense | |||||
| Income from continuing operations | |||||
| Loss from discontinued operations, net of tax benefit of $0.0, $0.0, and $0.3, respectively | |||||
| Net income | |||||
| Less: Income attributable to noncontrolling interests | |||||
| Net income attributable to ITT Inc. | |||||
| Basic: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Net income | |||||
| Diluted: | |||||
| Continuing operations | |||||
| Discontinued operations | |||||
| Net income | |||||
| Weighted average common shares – basic | |||||
| Weighted average common shares – diluted | |||||
| Amounts attributable to ITT Inc.: | |||||
| Income from continuing operations, net of tax | |||||
Loading...